Obese patients with partially controlled asthma: Weight control shows more benefit in IgE low patients

Edin Jusufovic (Tuzla, Bosnia and Herzegovina), Edin Jusufovic, Mitja Kosnik, Rifat Sejdinovic, Elida Turkusic, Munevera Osmic, Alma Nadarevic, Fransi Petrak, Dzenan Halilovic, Azra Jusufovic, Besim Prnjavorac

Source: International Congress 2016 – Asthma: mechanisms and biomarkers that promote clinical understanding
Session: Asthma: mechanisms and biomarkers that promote clinical understanding
Session type: Poster Discussion
Number: 574
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Edin Jusufovic (Tuzla, Bosnia and Herzegovina), Edin Jusufovic, Mitja Kosnik, Rifat Sejdinovic, Elida Turkusic, Munevera Osmic, Alma Nadarevic, Fransi Petrak, Dzenan Halilovic, Azra Jusufovic, Besim Prnjavorac. Obese patients with partially controlled asthma: Weight control shows more benefit in IgE low patients. Eur Respir J 2016; 48: Suppl. 60, 574

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Asthma control in children: Comparison of different lung function parameters
Source: Annual Congress 2013 –Asthma treatment and management in children
Year: 2013

Global evaluation of treatment effectiveness (GETE) is an accurate predictor of response to omalizumab in patients with severe allergic asthma: A pooled analysis
Source: International Congress 2014 – Intervening in allergic asthma
Year: 2014


Prediction of asthma control and treatment changes in obstructive asthmatic children
Source: International Congress 2016 – Techniques and tools in paediatric asthma
Year: 2016


Lung clearance index in pediatric patients with asthma
Source: Annual Congress 2013 –Asthma treatment and management in children
Year: 2013


Laser acupuncture effects on serum immunoglobulin E in A topic bronchial asthma patients
Source: International Congress 2016 – Preclinical pharmacology: drug targets and mechanisms of action
Year: 2016

P-PiXel: A ’real-life’ evaluation of omalizumab use in asthmatic patients
Source: International Congress 2016 – Asthma management
Year: 2016

Small airway indices, bronchodilator response and asthma control in children
Source: International Congress 2014 – Paediatric asthma: lung function testing and more
Year: 2014

Immunology indices in severe bronchial asthma with different levels of disease control in children
Source: Annual Congress 2013 –Asthma
Year: 2013


Lung clearance index in asthmatic patients
Source: International Congress 2016 – Techniques and tools in paediatric asthma
Year: 2016


Clinical phenotypes in asthmatic population with severe asthma
Source: International Congress 2015 – Clincal aspects of asthma: monitoring and mechanisms
Year: 2015

Study of the small airway and its role in pediatric asthma control assessment
Source: International Congress 2015 – Paediatric asthma and allergy: asthma management
Year: 2015


Positive bronchodilator response is a poor predictor of future risk in well controlled asthma patients
Source: International Congress 2016 – Functional assessment of the airways
Year: 2016

Long-term efficacy of omalizumab (OMA) for patients with severe allergic asthma (SAA). Clinical assessment and relationship to serum IgE concentrations
Source: International Congress 2015 – The immunology of allergic airway disease
Year: 2015


Autoreactivity in patients with combined COPD and asthma phenotype
Source: International Congress 2014 – Novel approaches to human studies in allergy and asthma
Year: 2014


LATE-BREAKING ABSTRACT: Predictors of lung function decline in a cohort of subjects with severe asthma
Source: International Congress 2015 – Monitoring airway diseases with lung function tests
Year: 2015


Study on sputum differential counts in asthmatics controlled & uncontrolled on inhaled corticosteroids
Source: International Congress 2015 – Non-exhaled biomarkers in the assessment of airways disease
Year: 2015


A clinically observed variability in serum total IgE in patients being considered for omalizumab therapy
Source: International Congress 2016 – Preclinical pharmacology: drug targets and mechanisms of action
Year: 2016

Real-world outcomes in patients receiving omalizumab for allergic asthma in India: Analysis by baseline IgE level
Source: Annual Congress 2013 –Treatment of asthma
Year: 2013


QAW039 (fevipiprant) improves lung function and control of asthma symptoms in patients with more severe air flow limitation: A proof-of-concept study
Source: International Congress 2015 – New targets and modalities for the treatment of asthma and COPD
Year: 2015


Variability of total serum IgE in moderate-to-severe asthmatic patients
Source: International Congress 2016 – Phenotyping and monitoring airway diseases
Year: 2016